|
![]() |
|||
|
||||
OverviewThe Pharmacological Guide to Montelukast opens by presenting the most recent updates on the improvement of montelukast stability and bioavailability, along with some innovative formulations produced by this research. Montelukast is a leukotriene modifier with bronchoprotective and anti-inflammatory actions frequently used in asthma management. As such, the authors go on to assess the impact of the addition of montelukast to ongoing asthma treatment in terms of improvement in clinical parameters, symptom control and quality of life. The closing chapter focuses on leukotrienes, formed by leukocytes, which are inflammatory mediators that play an active role in early and late-phase immune response. This group includes montelukast, zafirlukast and prankulast. Full Product DetailsAuthor: SÃ,ren C. DamPublisher: Nova Science Publishers Inc Imprint: Nova Science Publishers Inc Weight: 0.184kg ISBN: 9781536163940ISBN 10: 1536163945 Pages: 116 Publication Date: 01 August 2022 Audience: General/trade , General Format: Paperback Publisher's Status: Active Availability: Available To Order ![]() We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsPrefaceMontelukast Encapsulation at the Micro, Nano and Molecular ScaleMontelukast as Add-On Therapy to Asthma Treatment Improves Symptom Control and Quality of LifeThe Efficacy of Montelukast in the Treatment of Allergic RhinitisIndex.ReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |